On the 26th, Fine Medics, which entered the KOSDAQ market, succeeded in its double (stock price doubling compared to the offering price).
According to the Korea Exchange on the 26th, at 9:26 a.m., Fine Medics is trading at 20,400 won, which is up 10,400 won (104.00%) compared to the offering price of 10,000 won. Fine Medics rose as much as 158.50% immediately after the market opened.
Fine Medics, a gastrointestinal endoscope procedure corporations founded in 2009 by representative Jeon Seong-woo, a gastrointestinal doctor and professor, is receiving significant attention for its hybrid-type submucosal dissection knife (ESD-Knife), the world's first of its kind.
On the same day, MFC, a corporation specializing in raw pharmaceuticals, is trading at 6,280 won, down 560 won (8.19%) from the base price of 6,840 won at the same time.
Established in 2008, MFC is a raw pharmaceutical manufacturing and development company that went public on the KOSDAQ through a merger with Hana Financial 21 Special Purpose Acquisition Company (SPAC). Last year's sales were 17.3 billion won, with an operating profit of 700 million won.